Robert Wilson, a non-executive director at GlaxoSmithKline Plc, is to stand for re-election to the board for one further year from May 2013. Earlier this year, GSK said that Sir Robert would be stepping down next year. However given other changes on the board, he has agreed to continue in his role until May 2014. Sir Robert has been a chairman of BG Group Plc as well as executive chairman of Rio Tinto Plc. He was chairman of the Economist Group between 2003 and 2009.
GSK announced the decision on 26 September 2012.
Copyright 2012 Evernow Publishing Ltd